Year |
Citation |
Score |
2024 |
Lori A, Pearce BD, Katrinli S, Carter S, Gillespie CF, Bradley B, Wingo AP, Jovanovic T, Michopoulos V, Duncan E, Hinrichs RC, Smith A, Ressler KJ. Genetic risk for hospitalization of African American patients with severe mental illness reveals HLA loci. Frontiers in Psychiatry. 15: 1140376. PMID 38469033 DOI: 10.3389/fpsyt.2024.1140376 |
0.624 |
|
2021 |
Lori A, Avramopoulos D, Wang AW, Mulle J, Massa N, Duncan EJ, Powers A, Conneely K, Gillespie CF, Jovanovic T, Ressler KJ, Pearce BD. Polygenic risk scores differentiate schizophrenia patients with toxoplasma gondii compared to toxoplasma seronegative patients. Comprehensive Psychiatry. 107: 152236. PMID 33721583 DOI: 10.1016/j.comppsych.2021.152236 |
0.568 |
|
2020 |
Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, et al. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Frontiers in Psychiatry. 11: 833. PMID 33005152 DOI: 10.3389/Fpsyt.2020.00833 |
0.322 |
|
2020 |
Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. Journal of Abnormal Psychology. 129: 599-611. PMID 32757603 DOI: 10.1037/abn0000513 |
0.32 |
|
2020 |
Duncan E, Massa N, Goldsmith DR, Gandhi ZH, Hankus A, Alrohaibani A, Goel N, Cuthbert B, Fargotstein M, Barr DB, Panuwet P, Pearce BD. Toxoplasma Gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia Versus Control Subjects Biological Psychiatry. 87: S236. DOI: 10.1016/J.Biopsych.2020.02.612 |
0.325 |
|
2019 |
Massa N, Owens AV, Harmon W, Bhattacharya A, Ivleva EI, Keedy S, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort. Schizophrenia Research. PMID 31796306 DOI: 10.1016/J.Schres.2019.11.013 |
0.346 |
|
2019 |
Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. Jama Psychiatry. PMID 31389974 DOI: 10.1001/Jamapsychiatry.2019.2135 |
0.32 |
|
2019 |
Jovanovic T, Duncan EJ, Kaye J, Garza K, Norrholm SD, Inslicht SS, Neylan TC, Mathew SJ, Iosifescu D, Rothbaum BO, Mayberg HS, Dunlop BW. Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients. Psychophysiology. e13356. PMID 30807663 DOI: 10.1111/Psyp.13356 |
0.734 |
|
2019 |
Wang AW, Avramopoulos D, Lori A, Mulle J, Conneely K, Powers A, Duncan E, Almli L, Massa N, McGrath J, Schwartz AC, Goes FS, Weng L, Wang R, Yolken R, et al. Genome-wide association study in two populations to determine genetic variants associated with Toxoplasma gondii infection and relationship to schizophrenia risk. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30610941 DOI: 10.1016/J.Pnpbp.2018.12.019 |
0.601 |
|
2019 |
Lori A, Katrinli S, Carter S, Kerley K, Guffanti G, Gillespie C, Bradley B, Jovanovic T, Duncan E, Pearce BD, Hinrichs R, Smith A, Ressler KJ. S152. Genetic Risk for Hospitalization in Serious Mental Illness Biological Psychiatry. 85: S355-S356. DOI: 10.1016/J.Biopsych.2019.03.903 |
0.549 |
|
2018 |
Taylor N, Hollis JP, Corcoran S, Gross R, Cuthbert B, Swails LW, Duncan E. Impaired reward responsiveness in schizophrenia. Schizophrenia Research. PMID 29526451 DOI: 10.1016/J.Schres.2018.02.057 |
0.312 |
|
2018 |
Foss-Feig J, Velthorst E, Guillory S, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, et al. F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER Schizophrenia Bulletin. 44: S266-S266. DOI: 10.1093/Schbul/Sby017.649 |
0.344 |
|
2017 |
Fargotstein M, Hasenkamp W, Gross R, Cuthbert B, Green A, Swails L, Lewison B, Boshoven W, Keyes M, Duncan E. The effect of antipsychotic medications on acoustic startle latency in schizophrenia. Schizophrenia Research. PMID 28732798 DOI: 10.1016/J.Schres.2017.07.030 |
0.317 |
|
2017 |
Smith AK, Jovanovic T, Kilaru V, Lori A, Gensler L, Lee SS, Norrholm SD, Massa N, Cuthbert B, Bradley B, Ressler KJ, Duncan E. A Gene-Based Analysis of Acoustic Startle Latency. Frontiers in Psychiatry. 8: 117. PMID 28729842 DOI: 10.3389/Fpsyt.2017.00117 |
0.712 |
|
2017 |
Lori A, Avramopoulos D, Wang A, Goes FS, Mulle J, Powers A, McGrath JJ, Massa N, Weng L, Duncan E, Nestadt G, Conneely K, Wolyniec P, Wang R, Hopkins M, et al. 917. Genome-Wide Association Study (GWAS) of Toxoplasma Gondii Infection and Evaluation of Schizophrenia Risk by Using a Polygenic Risk Score (PRS) Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.643 |
0.48 |
|
2016 |
Massa NM, Duncan E, Jovanovic T, Kerley K, Weng L, Gensler L, Lee SS, Norrholm S, Powers A, Almli LM, Gillespie CF, Ressler K, Pearce BD. Relationship between Toxoplasma gondii Seropositivity and Acoustic Startle Response in an Inner-City Population. Brain, Behavior, and Immunity. PMID 27884623 DOI: 10.1016/J.Bbi.2016.11.021 |
0.734 |
|
2016 |
Wheeler MG, Duncan E, Davis M. Low Startle Magnitude May Be a Behavioral Marker of Vulnerability to Cocaine Addiction. Synapse (New York, N.Y.). PMID 27696533 DOI: 10.1002/Syn.21943 |
0.377 |
|
2016 |
Norrholm SD, Jovanovic T, Gerardi M, Breazeale KG, Price M, Davis M, Duncan E, Ressler KJ, Bradley B, Rizzo A, Tuerk PW, Rothbaum BO. Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. Behaviour Research and Therapy. 82: 28-37. PMID 27183343 DOI: 10.1016/J.Brat.2016.05.002 |
0.755 |
|
2016 |
Shim S, Shuman M, Duncan E. An emerging role of cGMP in the treatment of schizophrenia: A review. Schizophrenia Research. 170: 226-31. PMID 26706197 DOI: 10.1016/J.Schres.2015.11.015 |
0.321 |
|
2014 |
Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Trials. 15: 240. PMID 24950747 DOI: 10.1186/1745-6215-15-240 |
0.591 |
|
2014 |
Rothbaum BO, Price M, Jovanovic T, Norrholm SD, Gerardi M, Dunlop B, Davis M, Bradley B, Duncan EJ, Rizzo A, Ressler KJ. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. The American Journal of Psychiatry. 171: 640-8. PMID 24743802 DOI: 10.1176/Appi.Ajp.2014.13121625 |
0.753 |
|
2014 |
Gensler L, Jovanovic T, Smith A, Almli L, Norrholm S, Glover E, Ressler K, Bradley B, Duncan E. A candidate gene analysis of acoustic startle latency and psychosis F1000research. 5. DOI: 10.7490/F1000Research.1095681.1 |
0.675 |
|
2013 |
Pearce BD, Hubbard S, Rivera HN, Wilkins PP, Fisch MC, Hopkins MH, Hasenkamp W, Gross R, Bliwise N, Jones JL, Duncan E. Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls. Schizophrenia Research. 150: 258-61. PMID 23953218 DOI: 10.1016/J.Schres.2013.07.028 |
0.339 |
|
2013 |
Glover EM, Mercer KB, Norrholm SD, Davis M, Duncan E, Bradley B, Ressler KJ, Jovanovic T. Inhibition of fear is differentially associated with cycling estrogen levels in women. Journal of Psychiatry & Neuroscience : Jpn. 38: 341-8. PMID 23611176 DOI: 10.1503/Jpn.120129 |
0.748 |
|
2013 |
Koola MM, Qualls C, Kelly DL, Skelton K, Bradley B, Amar R, Duncan EJ. Prevalence of childhood physical and sexual abuse in veterans with psychiatric diagnoses. The Journal of Nervous and Mental Disease. 201: 348-52. PMID 23538982 DOI: 10.1097/Nmd.0B013E318288E333 |
0.319 |
|
2013 |
Jovanovic T, Sakoman AJ, Kozarić-KovaÄić D, MeÅ¡trović AH, Duncan EJ, Davis M, Norrholm SD. Acute stress disorder versus chronic posttraumatic stress disorder: inhibition of fear as a function of time since trauma. Depression and Anxiety. 30: 217-24. PMID 22907890 DOI: 10.1002/Da.21991 |
0.736 |
|
2012 |
Kohrt BA, Duncan E. Hemicrania Continua Headache in a Veteran with Posttraumatic Stress Disorder and Major Depressive Disorder without Traumatic Brain Injury. Case Reports in Psychiatry. 2012: 937217. PMID 22937418 DOI: 10.1155/2012/937217 |
0.375 |
|
2012 |
Kamkwalala A, Norrholm SD, Poole JM, Brown A, Donley S, Duncan E, Bradley B, Ressler KJ, Jovanovic T. Dark-enhanced startle responses and heart rate variability in a traumatized civilian sample: putative sex-specific correlates of posttraumatic stress disorder. Psychosomatic Medicine. 74: 153-9. PMID 22286850 DOI: 10.1097/Psy.0B013E318240803A |
0.744 |
|
2011 |
Norrholm SD, Anderson KM, Olin IW, Jovanovic T, Kwon C, Warren VT, McCarthy A, Bosshardt L, Sabree J, Duncan EJ, Rothbaum BO, Bradley B. Versatility of fear-potentiated startle paradigms for assessing human conditioned fear extinction and return of fear. Frontiers in Behavioral Neuroscience. 5: 77. PMID 22125516 DOI: 10.3389/Fnbeh.2011.00077 |
0.723 |
|
2011 |
Corcoran S, Norrholm SD, Cuthbert B, Sternberg M, Hollis J, Duncan E. Acoustic startle reduction in cocaine dependence persists for 1 year of abstinence. Psychopharmacology. 215: 93-103. PMID 21161186 DOI: 10.1007/S00213-010-2114-2 |
0.57 |
|
2010 |
Hasenkamp W, Epstein MP, Green A, Wilcox L, Boshoven W, Lewison B, Duncan E. Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families. Psychiatry Research. 178: 236-43. PMID 20483176 DOI: 10.1016/J.Psychres.2009.11.012 |
0.324 |
|
2010 |
Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B, Ressler KJ. Impaired fear inhibition is a biomarker of PTSD but not depression. Depression and Anxiety. 27: 244-51. PMID 20143428 DOI: 10.1002/Da.20663 |
0.764 |
|
2010 |
Jovanovic T, Norrholm SD, Blanding NQ, Phifer JE, Weiss T, Davis M, Duncan E, Bradley B, Ressler K. Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD. Psychoneuroendocrinology. 35: 846-57. PMID 20036466 DOI: 10.1016/J.Psyneuen.2009.11.009 |
0.778 |
|
2010 |
Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos AM, Myers KM, Davis M, Duncan EJ. Posttraumatic stress disorder may be associated with impaired fear inhibition: Relation to symptom severity | El trastorno de estrés postraumático puede asociarse a un deterioro de la inhibición del temor: relación con la gravedad de los síntomas Psiquiatria Biologica. 17: 119-126. DOI: 10.1016/J.Psiq.2010.12.001 |
0.665 |
|
2010 |
Norrholm SD, Jovanovic T, Rothbaum BO, Davis M, Hasenkamp W, Crowe C, Duncan E, Leimbach L, Skelton K, Bradley B. Optimization of research and clinical applications for combat-related posttraumatic stress disorder (PTSD): Progress through modern translational methodologies Optimization of Research and Clinical Applications For Combat-Related Posttraumatic Stress Disorder (Ptsd): Progress Through Modern Translational Methodologies. 1-63. |
0.661 |
|
2009 |
Jovanovic T, Blanding NQ, Norrholm SD, Duncan E, Bradley B, Ressler KJ. Childhood abuse is associated with increased startle reactivity in adulthood. Depression and Anxiety. 26: 1018-26. PMID 19691032 DOI: 10.1002/Da.20599 |
0.729 |
|
2009 |
Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos AM, Myers KM, Davis M, Duncan EJ. Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Research. 167: 151-60. PMID 19345420 DOI: 10.1016/J.Psychres.2007.12.014 |
0.755 |
|
2008 |
Norrholm SD, Vervliet B, Jovanovic T, Boshoven W, Myers KM, Davis M, Rothbaum B, Duncan EJ. Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans. Behavioral Neuroscience. 122: 1016-30. PMID 18823159 DOI: 10.1037/A0012604 |
0.721 |
|
2008 |
Hasenkamp W, Norrholm SD, Green A, Lewison B, Boshoven W, Keyes M, Duncan E. Differences in startle reflex and prepulse inhibition in European-Americans and African-Americans. Psychophysiology. 45: 876-82. PMID 18665868 DOI: 10.1111/J.1469-8986.2008.00680.X |
0.597 |
|
2007 |
Duncan E, Boshoven W, Harenski K, Fiallos A, Tracy H, Jovanovic T, Hu X, Drexler K, Kilts C. An fMRI study of the interaction of stress and cocaine cues on cocaine craving in cocaine-dependent men. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 174-82. PMID 17612820 DOI: 10.1080/10550490701375285 |
0.473 |
|
2007 |
Shipherd JC, Keyes M, Jovanovic T, Ready DJ, Baltzell D, Worley V, Gordon-Brown V, Hayslett C, Duncan E. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? Journal of Rehabilitation Research and Development. 44: 153-66. PMID 17551870 DOI: 10.1682/Jrrd.2006.06.0065 |
0.491 |
|
2007 |
Mittal VA, Hasenkamp W, Sanfilipo M, Wieland S, Angrist B, Rotrosen J, Duncan EJ. Relation of neurological soft signs to psychiatric symptoms in schizophrenia. Schizophrenia Research. 94: 37-44. PMID 17543502 DOI: 10.1016/J.Schres.2007.04.017 |
0.382 |
|
2006 |
Norrholm SD, Jovanovic T, Vervliet B, Myers KM, Davis M, Rothbaum BO, Duncan EJ. Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learning & Memory (Cold Spring Harbor, N.Y.). 13: 681-5. PMID 17142300 DOI: 10.1101/Lm.393906 |
0.717 |
|
2006 |
Duncan EJ, Bollini AM, Lewison B, Keyes M, Jovanovic T, Gaytan O, Egan G, Szilagyi S, Schwartz M, Parwani A, Chakravorty S, Rotrosen J. Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophrenia. Psychiatry Research. 145: 137-45. PMID 17070928 DOI: 10.1016/j.psychres.2006.04.006 |
0.489 |
|
2006 |
Jovanovic T, Norrholm SD, Keyes M, Fiallos A, Jovanovic S, Myers KM, Davis M, Duncan EJ. Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. Behavioral Neuroscience. 120: 995-1004. PMID 17014251 DOI: 10.1037/0735-7044.120.5.995 |
0.729 |
|
2005 |
Jovanovic T, Keyes M, Fiallos A, Myers KM, Davis M, Duncan EJ. Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm. Biological Psychiatry. 57: 1559-64. PMID 15953493 DOI: 10.1016/J.Biopsych.2005.02.025 |
0.637 |
|
2004 |
Duncan EJ, Szilagyi S, Schwartz MP, Bugarski-Kirola D, Kunzova A, Negi S, Stephanides M, Efferen TR, Angrist B, Peselow E, Corwin J, Gonzenbach S, Rotrosen JP. Effects of D-cycloserine on negative symptoms in schizophrenia. Schizophrenia Research. 71: 239-48. PMID 15474895 DOI: 10.1016/J.Schres.2004.03.013 |
0.348 |
|
2004 |
Jovanovic T, Szilagyi S, Chakravorty S, Fiallos AM, Lewison BJ, Parwani A, Schwartz MP, Gonzenbach S, Rotrosen JP, Duncan EJ. Menstrual cycle phase effects on prepulse inhibition of acoustic startle. Psychophysiology. 41: 401-6. PMID 15102125 DOI: 10.1111/1469-8986.2004.00166.X |
0.471 |
|
2003 |
Duncan E, Szilagyi S, Schwartz M, Kunzova A, Negi S, Efferen T, Peselow E, Chakravorty S, Stephanides M, Harmon J, Bugarski-Kirola D, Gonzenbach S, Rotrosen J. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol Psychiatry Research. 120: 1-12. PMID 14500109 DOI: 10.1016/S0165-1781(03)00161-6 |
0.346 |
|
2003 |
Duncan EJ, Szilagyi S, Efferen TR, Schwartz MP, Parwani A, Chakravorty S, Madonick SH, Kunzova A, Harmon JW, Angrist B, Gonzenbach S, Rotrosen JP. Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology. 167: 63-71. PMID 12632245 DOI: 10.1007/S00213-002-1372-Z |
0.361 |
|
2001 |
Duncan E, Madonick S, Chakravorty S, Parwani A, Szilagyi S, Efferen T, Gonzenbach S, Angrist B, Rotrosen J. Effects of smoking on acoustic startle and prepulse inhibition in humans Psychopharmacology. 156: 266-272. PMID 11549228 DOI: 10.1007/S002130100719 |
0.305 |
|
2001 |
Duncan EJ, Madonick SH, Parwani A, Angrist B, Rajan R, Chakravorty S, Efferen TR, Szilagyi S, Stephanides M, Chappell PB, Gonzenbach S, Ko GN, Rotrosen JP. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 72-83. PMID 11377920 DOI: 10.1016/S0893-133X(00)00240-2 |
0.353 |
|
2000 |
Duncan EJ, Adler LA, Stephanides M, Sanfilipo M, Angrist B. Akathisia and exacerbation of psychopathology: a preliminary report. Clinical Neuropharmacology. 23: 169-73. PMID 10895402 DOI: 10.1097/00002826-200005000-00008 |
0.334 |
|
2000 |
Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajan R, Sanfilipo M, Chappell PB, Chakravorty S, Gonzenbach S, Ko GN, Rotrosen JP. Impaired prepulse inhibition of acoustic startle in schizophrenia. Biological Psychiatry. 47: 662-9. PMID 10745060 DOI: 10.1016/S0006-3223(99)00148-1 |
0.354 |
|
1996 |
Sanfilipo M, Wolkin A, Angrist B, Van Kammen DP, Duncan E, Wieland S, Cooper TB, Peselow ED, Rotrosen J. Amphetamine and negative symptoms of schizophrenia Psychopharmacology. 123: 211-214. PMID 8741946 DOI: 10.1007/Bf02246180 |
0.343 |
|
1994 |
Wolkin A, Duncan E, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J. Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function Journal of Neural Transmission. 95: 49-61. PMID 7857586 DOI: 10.1007/Bf01283030 |
0.31 |
|
1993 |
Noponen M, Sanfilipo M, Samanich K, Ryer H, Ko G, Angrist B, Wolkin A, Duncan E, Rotrosen J. Elevated PLA2 activity in schizophrenics and other psychiatric patients Biological Psychiatry. 34: 641-649. PMID 8292693 DOI: 10.1016/0006-3223(93)90157-9 |
0.359 |
|
Show low-probability matches. |